Clarification of EMEA (European Medicines Evaluation Agency) role in device approvals sought
This article was originally published in Clinica
Executive Summary
Medical device manufacturers who have become frustrated by what they see as the European Agency for the Evaluation of Medicinal Products' over-involvement in the evaluation of medical devices containing derivatives of human blood or plasma can now hope for some clarification of the EMEA's role.